Lukas Scheibler - Jan 12, 2023 Form 4 Insider Report for Apellis Pharmaceuticals, Inc. (APLS)

Signature
/s/ David Watson, attorney-in-fact for Lukas Scheibler
Stock symbol
APLS
Transactions as of
Jan 12, 2023
Transactions value $
$1,867,956
Form type
4
Date filed
1/17/2023, 06:42 PM
Previous filing
May 31, 2022
Next filing
Jan 24, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APLS Common Stock Award $0 +22.6K +54.9% $0.00 63.7K Jan 12, 2023 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction APLS Stock Option (Right to Buy) Award $1.87M +35.5K $52.66 35.5K Jan 12, 2023 Common Stock 35.5K $52.66 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This represents a Restricted Stock Award granted 01/12/23 that vest annually from grant date over a four year period subject to continued service.
F2 This includes 769 shares from 04/29/2022 ESPP purchase.
F3 This represents a stock option award granted 01/12/2023 that vest over a four year period. 25% vest one year from grant date and the remaining 75% vest monthly thereafter subject to continued service.